Provalabs

Developer of microfluidic biochips for preclinical drug development

placeSeoul, Seoul, South Korea calendar_todayFounded 2021 language provalabs.com

Innovation

13 patent families (1 granted) — focus: Physics & computing, Chemistry & metallurgy, Operations & transport, Human necessities; filing pace accelerating. Cited 42 times.

YearFilings
20231
20247
20255
20262

Social engagement

Social engagement: 70 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

23 Jun 2026
Product launch
ScalloP® for Transwell by ProvaLabs
4 Jun 2026
Event
MPS World Summit 2026
21 May 2026
Event
MPS World Summit 2026
Coming soon